Correlation Between Oracle and Clearside Biomedical

Can any of the company-specific risk be diversified away by investing in both Oracle and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oracle and Clearside Biomedical, you can compare the effects of market volatilities on Oracle and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Clearside Biomedical.

Diversification Opportunities for Oracle and Clearside Biomedical

0.06

Correlation Coefficient

Oracle  Clearside Biomedical

Significant diversification

The 3 months correlation between Oracle and Clearside is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of Oracle i.e., Oracle and Clearside Biomedical go up and down completely randomly.

Pair Corralation between Oracle and Clearside Biomedical

Given the investment horizon of 90 days Oracle is expected to generate 0.49 times more return on investment than Clearside Biomedical. However, Oracle is 2.02 times less risky than Clearside Biomedical. It trades about 0.16 of its potential returns per unit of risk. Clearside Biomedical is currently generating about -0.01 per unit of risk. If you would invest  12,201  in Oracle on September 3, 2024 and sell it today you would earn a total of  6,283  from holding Oracle or generate 51.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oracle  vs.  Clearside Biomedical

Oracle

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Oracle are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal fundamental indicators, Oracle disclosed solid returns over the last few months and may actually be approaching a breakup point.

Clearside Biomedical

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Clearside Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearside Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oracle and Clearside Biomedical

The main advantage of trading using opposite Oracle and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.

The idea behind Oracle and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.